Medtronic plc.
medical device company
- Reports this week
- 0
- Active events
- 0
- Connections
- 218
What's happening
Earlier this month
-
MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.Well supported6 reports
-
Executive Vice President Michael Marinaro of Medtronic plc sold company stock on October 16, 2026.Some support1 report
-
Michael Carter has been appointed to lead Medtronic's Cranial and Spinal Technologies unit.Some support1 report
-
Abbott Laboratories and Medtronic plc operate within the healthcare device sector.Well supported7 reports1 development inside
-
Smithbridge Asset Management trimmed its holdings in Medtronic stock and filed a disclosure with the SEC.Some support8 reports
One to three months ago
-
Medtronic's Hugo robotic system will be complemented by Sentire, leveraging cardiac ablation solutions for growth.Some support1 report
-
MarketBeat listed Johnson & Johnson, Medtronic plc, and Eli Lilly and Company as top healthcare stocks on October 7, 2026.Some support2 reports
-
Wolfe Research upgraded Medtronic's stock rating on July 4, 2025, coinciding with the company announcing the integration of the Affera platform.Speculative3 reports
-
Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.Some support2 reports12 developments inside
-
Medtronic plc is a global healthcare technology company headquartered in Galway, Ireland, with executives including Thierry Piéton and Greg Smith.Well supported13 reports1 development inside
-
Medtronic announced it began its first surgical procedures in Europe, utilizing its advanced surgical systems in an Irish hospital.Some support1 report
-
Medtronic expands its Hugo system via investment and Jim Cramer views the company as a quandary stock.Some support2 reports
-
Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.Some support4 reports1 development inside
-
Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.Some support1 report
-
Medtronic acquired Given Imaging, and the FDA published an early alert regarding a product recall.Speculative1 report1 development inside
-
Johnson & Johnson, Medtronic plc, and Omega Healthcare are noted as major medical device makers and dividend-paying healthcare stocks.Some support4 reports4 developments inside
Gone quiet
No new reports in 90+ days-
Medtronic plc announced a collaboration with Orchestra BioMed Holdings to develop and commercialize AVIM therapy.Some support3 reports
-
Analysts at Wells Fargo raised price targets for Medtronic, while UBS analysts provided bullish notes on the company's prospects.Well supported3 reports
-
Medtronic plc announced it is seeking an expedited regulatory pathway for a technology.Some support2 reports
-
FDA granted clearance for Hugo's Instrument Exit Point, while CAS was expected to grow mid-to-high teens.Some support1 report
-
Market growth in the medical device sector, driven by cardiovascular disease trends, involving multiple companies like LivaNova, Medtronic, and Philips in Europe.Some support1 report1 development inside
-
Leerink partners adjusted its rating and target price for Medtronic plc on July 31, 2026.Some support1 report
-
Surgical-robot competition from Intuitive Surgical.Some support3 reports1 development inside
-
California State Teachers Retirement System trimmed its position in Medtronic shares and filed reports with the SEC.Some support2 reports
-
Citigroup cut its target price on Medtronic stock, and TD Cowen also lowered its price target for the company.Some support7 reports
-
Medtronic and Boston Scientific are expanding globally into emerging markets, operating in the MedSurg equipment space.Speculative1 report1 development inside
-
RETIA expanded its commercial relationship for distribution with Medtronic plc on July 1, 2026.Some support1 report
-
Institutional investors filed reports with the SEC regarding Medtronic plc.Some support1 report2 developments inside
-
Medtronic received a 'Buy' rating from TD Cowen, bolstered by favorable CMS coverage terms and the tailwinds of Trump-era tariffs benefiting AI stocks.Some support2 reports1 development inside
-
Medtronic plc filed required reports with the Securities and Exchange Commission.Some support7 reports
-
Analyst rating and price target updates for Medtronic, alongside required institutional investment disclosures filed with the SEC.Some support1 report
-
State of Wisconsin Investment Board cut its stake in Medtronic while SageView Advisory Group increased its stake.Some support1 report
-
David Roman trimmed the price target for Medtronic plc on June 15, 2026.Some support1 report
-
Truist Financial lowered its price objective for Medtronic plc stock.Some support1 report
-
Illinois Municipal Retirement Fund boosted its position in Medtronic shares.Some support1 report
-
Medtronic announced its intention to acquire SPR Therapeutics, while Goldman Sachs reinstated its coverage of Medtronic with a Neutral rating.Some support1 report
-
GE Healthcare, Medtronic plc, and Integra LifeSciences were identified as key players in the market as of August 21, 2025.Some support1 report
-
Stryker received FDA 510(k) clearance for its OptaBlate system, and Medtronic received clearance for OsteoCool 2.0.Some support2 reports
-
Philips, Medtronic, and Abbott Japan are identified as key players in the Remote Patient Monitoring (RPM) market.Some support1 report
-
General Electric, Medtronic plc, and Philips are leading players in the anaesthesia devices market and are anticipated to drive growth in the Asia-Pacific region.Speculative1 report
-
Medtronic plc is facing activist pressure from investors, leading to the appointment of an interim CEO, former CFO, and former CEO to the company board.Some support3 reports1 development inside
-
Medtronic appointed Dr. Joon Lee to its Board of Directors, whose qualifications include 25 years at UPMC, training at MGH, and certification by ABIM.Speculative1 report
-
Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.Speculative1 report1 development inside
-
FDA granted regulatory milestones to Medtronic, which is integrating with Abbott's Instinct sensor.Well supported3 reports2 developments inside
-
Agilent Technologies and Medtronic plc were noted to operate within the same industry.Speculative1 report
-
Medical device companies are advancing their products and market presence, including Intuitive Surgical leadership updates, market entry for Moon Surgical and CMR Surgical, and regulatory milestones for Medtronic in Europe.Speculative1 report2 developments inside
-
Alexander Zverev and Medtronic plc have formed a partnership aimed at raising awareness about diabetes.Speculative1 report
-
Medtronic is emerging as a strong competitor to Intuitive Surgical amid a surge in SP procedures, with Korea leading utilization.Some support7 reports
-
Philips and Medtronic expanded their collaboration to advance patient monitoring technologies.Some support5 reports
-
Medtronic is preparing for the spin-off of its MiniMed business unit, and Chad Spooner has been appointed as the new CFO of the entity.Some support4 reports
-
Trump's trade agenda and tariffs are currently impacting Medtronic plc.Speculative1 report
-
A summary of industry trends from July 11, 2025, noting the Humira patent expiration, Johnson & Johnson's consistency, and Medtronic's dividend increases.Some support2 reports
-
Intuitive Surgical and Medtronic participated in a telesurgery demonstration involving personnel from both companies, held in Strasbourg, France, with a console in Georgia.Some support1 report
-
Medtronic plc supports SpineHope's medical missions in Nicaragua, where Monica Santamaria resided.Some support1 report
-
Carlsmed's custom medical devices are entering a competitive market against products from Johnson & Johnson, Globus Medical, and Medtronic plc.Some support1 report
-
Medtronic plc secured the CE Mark for its MiniMed™ 780G system in Europe.Some support1 report
-
Market growth in the Urology Care Devices & Platforms Market is being driven by advanced diagnostics and procedures.Some support2 reports1 development inside
-
Medtronic's TAVR systems were found to infringe on Colibri's patented method, but the ruling was overturned by the US Court of Appeals.Some support1 report
-
Abbott Laboratories, Medtronic plc, and Merck KGaA are key players in the Cardiac Tissue Engineering Market.Some support1 report
-
Johnson & Johnson and Medtronic are noted as good dividend stocks while also dealing with a huge class-action lawsuit.Some support2 reports
No events began in the chosen period. Widen it, or reset.
What's reaching Medtronic plc
Events traced to Medtronic plc, step by step, newest firstExplainers that pass through Medtronic plc
Medtronic plc is a step on the way to someone else- Medtronic's surgical robot entry increases competition for Johnson & JohnsonMedtronic's surgical robot entry increases competition for Johnson & JohnsonPossible
- Medtronic's surgical robot entry could challenge Boston Scientific's market shareMedtronic's move into surgical robotics may intensify competition for Boston Scientific.Possible
Around Medtronic plc this week
News at the entities that move Medtronic plc most-
FDA StructuralFDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.Moves Medtronic plc
-
SEC StructuralGap Inc. filed with the SEC regarding institutional investment activity, and Jefferies downgraded its stock rating and target price.Moves Medtronic plc
-
Ireland StructuralA New Hampshire native is running a culinary pop-up business in Ireland, promoting her food on Instagram.Moves Medtronic plc
-
Elliott Investment Management StructuralPepsiCo is facing activist pressure from Elliott Management while also being compared to its archrival, The Coca-Cola Company.Moves Medtronic plc
-
Food and Drug Administration StructuralThe Food and Drug Administration approved Bayer's new blood thinner on November 9th.Moves Medtronic plc
-
Medicare OperationalA study analyzed patient compliance in the insurance context, informed by Gallup data regarding Medicare coverage.Moves Medtronic plc
Connections
The 40 strongest of 218, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Securities and Exchange Commission Structural
Medtronic plc is formally required to file periodic reports and disclosures with the SEC as part of its ongoing regulatory compliance.
-
Ireland Structural
Medtronic plc is incorporated and headquartered in Ireland, establishing a foundational structural base.
-
FDA Structural
The FDA formally regulates Medtronic's medical devices, granting clearances, approvals, and managing recalls.
-
Thierry Piéton Structural
Thierry Piéton holds an executive position, including CFO, at Medtronic plc.
-
SEC Structural
Medtronic plc is subject to formal regulatory oversight and disclosure requirements by the SEC.
-
Elliott Investment Management Structural
Elliott Investment Management exerts activist pressure as a major shareholder, influencing Medtronic's board and strategic focus.
-
Hugo Structural
Medtronic is developing and expanding the Hugo robotic-assisted surgery system through investment and complementary product integration.
-
Food and Drug Administration Structural
The FDA formally regulates Medtronic plc, issuing recalls and alerts regarding product safety.
Show all 40 connections
-
Intuitive Surgical Operational
Intuitive Surgical and Medtronic plc are active competitors in the robotic-assisted surgery and medical device market.
-
Royal National Orthopaedic Hospital Structural
Medtronic supplies surgical systems to the Royal National Orthopaedic Hospital.
-
Amundi Transactional
Amundi increased its investment position in Medtronic stock.
-
Illinois Municipal Retirement Fund Transactional
The fund increased its investment holdings in Medtronic plc shares.
-
Johnson & Johnson Operational
Johnson & Johnson and Medtronic are direct competitors and peers in the medical device and healthcare sectors.
-
Medicare Operational
Medtronic operates within the market governed by Medicare, which imposes specific reimbursement constraints on its products and services.
-
Boston Scientific Operational
The companies are major medical device manufacturers that actively compete in the MedSurg equipment market.
-
Donald Trump Structural
Donald Trump's trade policies and tariffs directly affect Medtronic plc.
-
Truist Financial Transactional
Truist Financial lowered its price objective on Medtronic plc stock.
-
Capital Research Global Investors Transactional
Capital Research Global Investors boosted its position in Medtronic plc, resulting in a 12.6% increase in valuation during the 4th quarter.
-
Leerink partners Mentioned together
Leerink partners provides market research and analysis on Medtronic plc's stock performance.
-
representative Transactional
The representative sold Medtronic plc stock in a transaction valued between $1,001 and $15,000.
-
Stryker Corporation Operational
Stryker Corporation and Medtronic plc are competitors operating within the medical device market.
-
RETIA Operational
The relationship is characterized by an ongoing, expanded commercial partnership focused on market distribution.
-
Abbott Laboratories Operational
Both Abbott and Medtronic are identified as key competitors and players within the healthcare device and tissue engineering markets.
-
Citigroup Mentioned together
Citigroup has issued a target price recommendation regarding Medtronic stock.
-
BofA Securities, Inc. Transactional
BofA Securities acted as dealer manager for Medtronic's exchange offer.
-
Invest Mentioned together
The entities are co-mentioned in the context of stock performance and investment appeal.
-
Jacob Greenberg Operational
Jacob Greenberg led a study evaluating Medtronic's Hugo system.
-
Humana Mentioned together
Both Medtronic plc and Humana are identified as major players within the healthcare sector.
-
TD Cowen Mentioned together
TD Cowen provides sell-side analyst coverage, including ratings and price target updates, for Medtronic plc.
-
Danaher Corporation Mentioned together
Both companies are identified as major players within the healthcare sector.
-
Michael Carter Structural
Michael Carter is a leader within Medtronic plc's Cranial and Spinal Technologies unit.
-
China Shared context
Medtronic operates within the market and regulatory context of China, specifically regarding surgical systems co-distribution.
-
State of Wisconsin Investment Board Transactional
The State of Wisconsin Investment Board reduced its investment stake in Medtronic plc.
-
Morgan Stanley Mentioned together
Morgan Stanley provides professional market coverage and price targets for Medtronic plc.
-
Bank of America Mentioned together
Bank of America issues research reports analyzing Medtronic plc.
-
SageView Advisory Group Transactional
SageView Advisory Group increased its investment stake in Medtronic plc.
-
Jim Cramer Mentioned together
Jim Cramer provides market commentary and warnings regarding Medtronic's stock status and strategic issues.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group issued a 'hold' rating and set an $88 price target for Medtronic plc.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada provides financial analysis, including ratings and price targets, for Medtronic plc.
-
MarketBeat Mentioned together
MarketBeat uses its financial tools to track and report on Medtronic's stock performance and dividend status.
History
Events by the month they beganOctober 2026
4 events- Executive Vice President Michael Marinaro of Medtronic plc sold company stock on October 16, 2026.
- Michael Carter has been appointed to lead Medtronic's Cranial and Spinal Technologies unit.
- Medtronic's Hugo robotic system will be complemented by Sentire, leveraging cardiac ablation solutions for growth.
- MarketBeat listed Johnson & Johnson, Medtronic plc, and Eli Lilly and Company as top healthcare stocks on October 7, 2026.
September 2026
3 events- MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.
- Medtronic announced it began its first surgical procedures in Europe, utilizing its advanced surgical systems in an Irish hospital.
- Medtronic expands its Hugo system via investment and Jim Cramer views the company as a quandary stock.
August 2026
4 events- Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.
- Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.
- Medtronic plc announced it is seeking an expedited regulatory pathway for a technology.
- FDA granted clearance for Hugo's Instrument Exit Point, while CAS was expected to grow mid-to-high teens.
Show 2 earlier months
July 2026
5 events- Smithbridge Asset Management trimmed its holdings in Medtronic stock and filed a disclosure with the SEC.
- Leerink partners adjusted its rating and target price for Medtronic plc on July 31, 2026.
- California State Teachers Retirement System trimmed its position in Medtronic shares and filed reports with the SEC.
- Citigroup cut its target price on Medtronic stock, and TD Cowen also lowered its price target for the company.
- RETIA expanded its commercial relationship for distribution with Medtronic plc on July 1, 2026.
June 2026
44 events- Abbott Laboratories and Medtronic plc operate within the healthcare device sector.
- Wolfe Research upgraded Medtronic's stock rating on July 4, 2025, coinciding with the company announcing the integration of the Affera platform.
- Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.
- Medtronic plc is a global healthcare technology company headquartered in Galway, Ireland, with executives including Thierry Piéton and Greg Smith.
- Medtronic acquired Given Imaging, and the FDA published an early alert regarding a product recall.
- Johnson & Johnson, Medtronic plc, and Omega Healthcare are noted as major medical device makers and dividend-paying healthcare stocks.
- Medtronic plc announced a collaboration with Orchestra BioMed Holdings to develop and commercialize AVIM therapy.
- Analysts at Wells Fargo raised price targets for Medtronic, while UBS analysts provided bullish notes on the company's prospects.
- Market growth in the medical device sector, driven by cardiovascular disease trends, involving multiple companies like LivaNova, Medtronic, and Philips in Europe.
- Surgical-robot competition from Intuitive Surgical.
- Medtronic and Boston Scientific are expanding globally into emerging markets, operating in the MedSurg equipment space.
- Institutional investors filed reports with the SEC regarding Medtronic plc.
- Medtronic received a 'Buy' rating from TD Cowen, bolstered by favorable CMS coverage terms and the tailwinds of Trump-era tariffs benefiting AI stocks.
- Medtronic plc filed required reports with the Securities and Exchange Commission.
- Analyst rating and price target updates for Medtronic, alongside required institutional investment disclosures filed with the SEC.
- State of Wisconsin Investment Board cut its stake in Medtronic while SageView Advisory Group increased its stake.
- David Roman trimmed the price target for Medtronic plc on June 15, 2026.
- Truist Financial lowered its price objective for Medtronic plc stock.
- Illinois Municipal Retirement Fund boosted its position in Medtronic shares.
- Medtronic announced its intention to acquire SPR Therapeutics, while Goldman Sachs reinstated its coverage of Medtronic with a Neutral rating.
- GE Healthcare, Medtronic plc, and Integra LifeSciences were identified as key players in the market as of August 21, 2025.
- Stryker received FDA 510(k) clearance for its OptaBlate system, and Medtronic received clearance for OsteoCool 2.0.
- Philips, Medtronic, and Abbott Japan are identified as key players in the Remote Patient Monitoring (RPM) market.
- General Electric, Medtronic plc, and Philips are leading players in the anaesthesia devices market and are anticipated to drive growth in the Asia-Pacific region.
- Medtronic plc is facing activist pressure from investors, leading to the appointment of an interim CEO, former CFO, and former CEO to the company board.
- Medtronic appointed Dr. Joon Lee to its Board of Directors, whose qualifications include 25 years at UPMC, training at MGH, and certification by ABIM.
- Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.
- FDA granted regulatory milestones to Medtronic, which is integrating with Abbott's Instinct sensor.
- Agilent Technologies and Medtronic plc were noted to operate within the same industry.
- Medical device companies are advancing their products and market presence, including Intuitive Surgical leadership updates, market entry for Moon Surgical and CMR Surgical, and regulatory milestones for Medtronic in Europe.
- Alexander Zverev and Medtronic plc have formed a partnership aimed at raising awareness about diabetes.
- Medtronic is emerging as a strong competitor to Intuitive Surgical amid a surge in SP procedures, with Korea leading utilization.
- Philips and Medtronic expanded their collaboration to advance patient monitoring technologies.
- Medtronic is preparing for the spin-off of its MiniMed business unit, and Chad Spooner has been appointed as the new CFO of the entity.
- Trump's trade agenda and tariffs are currently impacting Medtronic plc.
- A summary of industry trends from July 11, 2025, noting the Humira patent expiration, Johnson & Johnson's consistency, and Medtronic's dividend increases.
- Intuitive Surgical and Medtronic participated in a telesurgery demonstration involving personnel from both companies, held in Strasbourg, France, with a console in Georgia.
- Medtronic plc supports SpineHope's medical missions in Nicaragua, where Monica Santamaria resided.
- Carlsmed's custom medical devices are entering a competitive market against products from Johnson & Johnson, Globus Medical, and Medtronic plc.
- Medtronic plc secured the CE Mark for its MiniMed™ 780G system in Europe.
- Market growth in the Urology Care Devices & Platforms Market is being driven by advanced diagnostics and procedures.
- Medtronic's TAVR systems were found to infringe on Colibri's patented method, but the ruling was overturned by the US Court of Appeals.
- Abbott Laboratories, Medtronic plc, and Merck KGaA are key players in the Cardiac Tissue Engineering Market.
- Johnson & Johnson and Medtronic are noted as good dividend stocks while also dealing with a huge class-action lawsuit.